C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A01K 67/027 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C12N 15/63 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2430712
The invention concerns the genomic DNA, cDNA , and polypeptide sequences of CanIon, a voltage gated ion channel protein. The invention also concerns biallelic markers of the CanIon gene. The CanIon gene may be used as a biological target for the treatment and diagnosis of schizophrenia, bipolar disorder, and other diseases and conditions.
L'invention concerne l'ADN génomique, l'ADNc et les séquences polypeptidiques de CanIon, une protéine du canal ionique dépendant du potentiel. L'invention concerne également des marqueurs biallèles du gène CanIon. Le gène CanIon peut être utilisé comme cible biologique dans le traitement et le diagnostic de la schizophrénie, de troubles à forme bipolaires et d'autres pathologies ou troubles.
Abderrahim Hadi
Chumakov Ilya
Cohen Daniel
Simon Anne-Marie
Genset S.a.
Serono Genetics Institute S.a.
Sim & Mcburney
LandOfFree
Schizophrenia-related voltage-gated ion channel gene and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Schizophrenia-related voltage-gated ion channel gene and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Schizophrenia-related voltage-gated ion channel gene and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1426007